Lei Tu
Impact in
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 2%
- Long-Term Effects of COVID-19
Papers in
-
- COVID-19 Clinical Research Studies 8
- SARS-CoV-2 and COVID-19 Research 4
- Genetics 11
- Inflammatory Bowel Disease 9
- Co-authors
- Guogang Xu (6 shared papers)Runsheng Wang (6 shared papers)Qinyong Hu (4 shared papers)Tianzhi Li (4 shared papers)Yingzhen Du (4 shared papers)Chao Hu (4 shared papers)Mi Mu (3 shared papers)Pengcheng Yang (2 shared papers)
- Journals
- Neurogastroenterology & Motility (5 papers)Oncotarget (3 papers)Journal of Immunology Research (2 papers)Frontiers in Immunology (2 papers)American Journal of Respiratory and Critical Care Medicine (1 paper)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Lei Tu
59 papers receiving 3.3k citations
Lei Tu's Hit Papers
Peers
Comparison fields: 5 of 147
- Infectious Diseases 1.5k
- Neurology 670
- Gastroenterology 129
- Applied Microbiology and Biotechnology 34
- Oncology 426
Countries citing papers authored by Lei Tu
This map shows the geographic impact of Lei Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Tu more than expected).
Fields of papers citing papers by Lei Tu
This network shows the impact of papers produced by Lei Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Tu. The network helps show where Lei Tu may publish in the future.
Co-authors
The 25 scholars most cited alongside Lei Tu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study Hit paper breakdown → | 2020 | 1330 |
| 2 | Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study Hit paper breakdown → | 2020 | 699 |
| 3 | 2020 | 147 | |
| 4 | 2019 | 136 | |
| 5 | 2017 | 132 | |
| 6 | 2021 | 123 | |
| 7 | 2020 | 70 | |
| 8 | 2020 | 67 | |
| 9 | 2019 | 67 | |
| 10 | 2020 | 50 | |
| 11 | 2020 | 44 | |
| 12 | 2017 | 40 | |
| 13 | 2017 | 37 | |
| 14 | 2013 | 32 | |
| 15 | 2019 | 29 | |
| 16 | 2013 | 29 | |
| 17 | 2017 | 28 | |
| 18 | 2015 | 24 | |
| 19 | 2021 | 21 | |
| 20 | 2020 | 21 |
About Lei Tu
Lei Tu is a scholar working on Infectious Diseases, Genetics, Immunology, Surgery and Gastroenterology, having authored 62 papers that have together received 3.4k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (9 papers), COVID-19 Clinical Research Studies (8 papers), Vagus Nerve Stimulation Research (4 papers), Long-Term Effects of COVID-19 (4 papers), Eosinophilic Esophagitis (4 papers), SARS-CoV-2 and COVID-19 Research (4 papers), IL-33, ST2, and ILC Pathways (4 papers) and Gastroesophageal reflux and treatments (3 papers). The work is most often cited by research in Infectious Diseases (1.5k citations), Neurology (670 citations), Gastroenterology (129 citations), Applied Microbiology and Biotechnology (34 citations) and Oncology (426 citations). Lei Tu has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Guogang Xu, Runsheng Wang, Qinyong Hu, Tianzhi Li, Yingzhen Du, Chao Hu, Mi Mu, Pengcheng Yang, Yu Sun and Pibao Li. Their work appears in journals such as Neurogastroenterology & Motility, Oncotarget, Journal of Immunology Research, Frontiers in Immunology and American Journal of Respiratory and Critical Care Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.